Page 102 - BPOM Terbitkan EUA Vaksin Indovac dan Vaksin AWcorna

Judul : IndoVac Be the First Vaccine COVID-19 Made in Indonesia
Nama Media : viva.co.id
Tanggal : 9/30/2022
Halaman/URL : https://www.viva.co.id/english/1527322-indovac-be-the-first-vaccine-
covid-19-made-in-indonesia
Tipe Media : Media Online

Head of the Food and Drug
Supervisory Agency (BPOM), Penny
K Lukito said Merah Putih Vaccine
with the trademark IndoVac is the
first COVID-19 vaccine that
producing in Indonesia through PT
Bio Farma's production facility in
Bandung, West Java.

During a press conference for the
issuance of an Emergency Use
Permit (EUA) for Domestic COVID-
19 Vaccines at the BPOM RI
Building, Jakarta, on Friday,
September 30, 2022, Penny K Lukito said the IndoVac Vaccine was the first COVID-19
vaccine to be produced locally in the country.

BPOM issued an Emergency Use Authorization (EUA) for the IndoVac Vaccine on September
24, 2022.

The emergency use permit is the initial door of access to obtain the COVID-19 vaccine that
the community needs as a strategic effort in dealing with the pandemic and protecting against
COVID-19.

Penny K Lukito conveyed that IndoVac is a COVID-19 vaccine containing the active
substance recombinant Receptor-Binding Domain (RBD) protein S of the SARS-Cov-2 virus
with a recombinant protein subunit platform developed by PT Bio Farma in collaboration with
Baylor College of Medicine, USA.

By EUA requirements, BPOM has previously evaluated the aspects of the efficacy, safety, and
quality of the IndoVac Vaccine by referring to the internationally applicable COVID-19
vaccine evaluation standards, as well as evaluating the fulfillment of Good Manufacturing